A Phase II Study of Sorafenib Combined With Cetuximab in EGFR-Expressing, KRAS-Mutated Metastatic Colorectal Cancer
Do, Khanh, Cao, Liang, Kang, Zhigang, Turkbey, Baris, Lindenberg, Maria L., Larkins, Erin, Holkova, Beata, Steinberg, Seth M., Raffeld, Mark, Peer, Cody J., Figg, William D., Eugeni, Michelle, Jacobs,Language:
english
Journal:
Clinical Colorectal Cancer
DOI:
10.1016/j.clcc.2015.02.007
Date:
March, 2015
File:
PDF, 801 KB
english, 2015